Infectious Disease HIV
Source: SGS Life Sciences Services
In the last five years, SGS completed 230 Infectious Disease clinical trials in more than 15,000 healthy subjects and patients, spanning the full spectrum of SGS services from Phase I through Phase IV, including scientific consulting for drug development programs, regulatory consulting, clinical site recruitment, clinical trial monitoring and management, biometrics, and pharmacovigilance.
In the last five years, SGS completed 230 Infectious Disease clinical trials in more than 15,000 healthy subjects and patients, spanning the full spectrum of SGS services from Phase I through Phase IV, including scientific consulting for drug development programs, regulatory consulting, clinical site recruitment, clinical trial monitoring and management, biometrics, and pharmacovigilance.
Studies conducted in:
- HIV
- Hepatitis C
- Influenza
- Hepatitis B
- Meningitis
- Fungal Infections
HIV & HCV Clinical Trial Case Studies
SGS has demonstrated its ability to help clients move through the clinical trial process quickly and successfully including:
- Contributions to 2 HIV products recently approved by the FDA (one designated as Fast Track) and EMEA
- Focused site selection targeting fast recruitment including enrollment of 38 HCV patients in 5 days of recruitment
- Combined protocol (SAD, MAD, POC) enrolling 18 healthy volunteers and 18 HCV patients in Belgium and Eastern Europe.
This website uses cookies to ensure you get the best experience on our website. Learn more